Gastritis: Symptoms, Causes, Diet, and Treatment

What is Gastritis?

The word gastritis describes a group of conditions that share one common feature: inflammation of the gastric mucosa, the inner lining of the stomach.

The gastric mucosa is composed of specialized cells responsible for producing:

• Acid and digestive enzymes that help break down food during digestion
• Mucus and bicarbonate, which protect the stomach lining from the very acids and enzymes it produces, preventing self-digestion

When the gastric mucosa becomes inflamed, the production of both secretions decreases, particularly the protective substances that normally coat and shield the stomach walls from acid damage. This leaves the stomach progressively more vulnerable to injury.

Gastritis can manifest in two fundamental patterns:

• Acute gastritis: Appears suddenly and lasts for a short period of time
• Chronic gastritis: Develops gradually and persists over months or years, in some cases progressing to gastric ulcer and increasing the risk of stomach cancer

An important clinical distinction is between:

• Erosive gastritis: Causes actual physical damage to the stomach lining, including sores, erosions, and ulcers. It is associated with bleeding and more severe symptoms.
• Non-erosive gastritis: Produces inflammation of the mucosal lining without erosions, often with milder or absent symptoms.

The inflammation is frequently caused by infection with Helicobacter pylori, the same bacterium responsible for most peptic ulcers. However, other factors including trauma, regular NSAID use, and heavy alcohol consumption can also trigger gastritis.

The most common symptoms of gastritis include:

• A feeling of indigestion or upset stomach
• Stomach pain or burning sensation
• Nausea and vomiting
• Excessive fullness after meals

In erosive gastritis, additional symptoms may include significant pain, gastrointestinal bleeding, and ulcerations.

For most people, gastritis does not represent a serious problem and resolves quickly with appropriate treatment. However, if neglected, it can last for years and lead to significant complications.

Difference Between Gastritis and Gastroenteritis

These two conditions are frequently confused, but they are distinct:

Gastroenteritis (often incorrectly called “intestinal flu”) involves inflammation of both the stomach and the intestines, caused by an infection (typically viral, more rarely bacterial). Gastritis, by contrast, is limited to inflammation of the stomach lining and is not always caused by an infection.

---

Causes

The walls of the stomach are normally protected by a mucous membrane that acts as a barrier against the digestive acids. These acids are so corrosive that, without adequate protection, they would literally digest the stomach itself. When this protective barrier weakens, digestive juices can damage and inflame the stomach walls, causing gastritis.

Helicobacter Pylori Infection

Infection caused by the bacterium [Helicobacter pylori (H. pylori) is the leading cause of gastric ulcer and is responsible for a large proportion of gastritis cases, in most cases producing chronic gastritis.

It is estimated that approximately half of the world’s population has been infected by this bacterium, which is capable of person-to-person transmission. Most infected individuals never experience complications, but in some people the bacterium disrupts the inner mucous lining of the stomach, causing structural changes to the gastric walls.

It is not fully understood why only approximately 20% of infected people develop complications. Current evidence suggests that vulnerability may be influenced by:

• Genetic predisposition (hereditary susceptibility)
• Lifestyle factors: smoking, high stress levels, dietary patterns

Transmission routes: H. pylori appears to be uniquely adapted to the human stomach, as humans serve as its only known natural reservoir. The most likely transmission routes are:

• Oral-oral transmission: The bacterium has been isolated in dental plaque and saliva, suggesting possible person-to-person spread through close contact (kissing, shared utensils)
• Fecal-oral transmission: The bacterium has demonstrated survival in water for several days, suggesting possible contamination of food or water sources by fecal material from infected individuals

NSAIDs and Other Substances

Regular and/or excessive use of **non-steroidal anti-inflammatory drugs (NSAIDs)s. These medications include:

• Aspirin
• Ibuprofen
• Ketoprofen
• Naproxen

NSAIDs inhibit the enzyme cyclooxygenase (COX), which is responsible for producing prostaglandins. These substances stimulate mucus and bicarbonate production in the stomach. By blocking prostaglandin synthesis, NSAIDs strip away the stomach’s protective barrier, leaving the mucosa vulnerable to acid damage. NSAIDs account for approximately 20% of all gastritis cases.

Other substances that can damage the gastric mucosa include:

• Alcohol: Directly irritates and erodes the gastric lining, making the stomach more vulnerable to digestive acids
• Cocaine: Causes mucosal ischemia (impaired blood flow) and direct toxicity
• Bile reflux: Bile is a fluid produced by the liver and stored in the gallbladder that aids in fat digestion. Normally, a valve (the pyloric sphincter) prevents bile from refluxing back into the stomach from the intestine. If this valve malfunctions, bile can regurgitate into the stomach, causing chemical irritation and chronic gastritis

Autoimmune Gastritis

In this form of gastritis, the immune system mistakenly attacks healthy stomach cells, treating them as a foreign threat. Specifically, autoantibodies target:

• Parietal cells (which produce gastric acid and intrinsic factor)
• Intrinsic factor itself (essential for vitamin B12 absorption)

Autoimmune gastritis occurs more frequently in patients who already have other autoimmune conditions, such as Hashimoto’s thyroiditis, type 1 diabetes mellitus, or vitiligo. It is also more prevalent in elderly populations. It is generally non-erosive and often progresses silently for years before clinical consequences emerge.

Other Causes

Less common causes of gastritis include:

• Stress, but only in cases of severe physiological stress such as major trauma, critical illness, extensive burns, or major surgery. The proposed mechanism involves reduced blood flow to the stomach, impairing its ability to produce the protective mucous layer. (Note: Everyday psychological stress is more commonly linked to functional dyspepsia than to true gastritis. For more details, see our article on nervous gastritis and functional dyspepsia)

• Systemic diseases: Including HIV/AIDS, Crohn’s disease, and parasitic infections

• Radiation therapy: To the upper abdomen can directly damage the gastric mucosa

• Certain medical procedures: Such as surgeries involving the stomach or duodenum

A Note on Diet: Current evidence does not support the idea that specific foods, such as spicy foods or coffee, cause gastritis in people with a healthy stomach. However, they can significantly worsen symptoms in individuals who already have gastritis and should be avoided during active disease.

---

Symptoms

Gastritis does not always produce noticeable signs or symptoms. When symptoms do occur, they vary depending on whether the condition is acute or chronic:

Acute Gastritis

Appears suddenly and is more likely to cause:

• Sudden-onset nausea and vomiting
• Intense burning or discomfort in the upper abdomen
• Epigastric pain (pain in the pit of the stomach)

Chronic Gastritis

Develops gradually and tends to cause:

• Dull, persistent stomach ache in the upper abdomen
• Sensation of a full stomach even after small meals
• Loss of appetite: feeling full after only a few bites
• Unexplained weight loss
• Belching or bloating

Many patients with chronic gastritis experience no symptoms at all. Instead, the condition is often discovered incidentally during endoscopy performed for other reasons.

Common Symptoms Across Both Types

• Dull or burning pain in the upper abdomen (heartburn)
• Nausea with or without vomiting
• Decreased appetite
• Belching or bloating
• A sense of fullness after meals

The pain may improve or worsen with eating, depending on the underlying cause and type of gastritis.

Symptoms of Erosive Gastritis / Complications

In cases of erosive gastritis or when significant bleeding has occurred:

• Presence of blood in vomit (hematemesis) may appear as bright red blood or dark coffee-ground material
• Black, tarry stools (melena), which indicate digested blood from upper GI bleeding
• Symptoms of anemia (fatigue, pallor, shortness of breath)

---

When to Call a Doctor

Most of us have experienced an episode of stomach upset or heartburn at some point in our lives. Most cases are brief and manageable with over-the-counter antacids. However, medical evaluation is recommended in the following situations:

See Your Doctor if:

• Symptoms persist for one week or more without improvement
• Pain is particularly severe or disabling
• Symptoms may be related to a medication you are taking (NSAIDs or other drugs)
• You experience unintentional weight loss
• Symptoms interfere significantly with daily life or sleep

Go to the Emergency Room Immediately if You Experience:

• Shortness of breath or rapid heart rate
• Dizziness or near-fainting
• Blood in vomit (bright red or coffee-ground appearance)
• Black, tarry stools (melena), which indicate digested blood
• Bright red blood in stool
• Significant weakness
• Pallor, which may suggest anemia from blood loss

These symptoms may indicate active upper gastrointestinal bleeding, which is a medical emergency requiring immediate intervention.

---

Health Risks

The outcome of gastritis depends strongly on its underlying cause, but is generally favorable with appropriate treatment. Most cases of non-specific acute gastritis resolve completely.

However, untreated or inadequately managed chronic gastritis carries significant long-term risks:

Peptic Ulcer Disease

Chronic inflammation gradually weakens the mucosal barrier, which can eventually result in the development of peptic ulcers: open sores in the stomach or duodenal lining. For more details, visit peptic ulcers.

Gastric Polyps and Tumors

Chronic gastric inflammation increases the risk of both benign gastric polyps and malignant tumors. The risk is particularly elevated in patients with:

• H. pylori-associated chronic gastritis (increased risk of gastric adenocarcinoma and gastric MALT lymphoma)
• Autoimmune gastritis (increased risk of gastric carcinoid tumors due to chronic hypergastrinemia)

Atrophic Gastritis

Some individuals with H. pylori-associated or autoimmune chronic gastritis can lead to atrophic gastritis, a condition where the gastric glands are gradually destroyed and replaced by fibrous or metaplastic tissue. This represents a significant step in the Correa carcinogenic cascade leading toward gastric cancer.

Anemia

In cases of erosive gastritis with chronic low-grade bleeding, iron-deficiency anemia can develop due to sustained blood loss. In autoimmune gastritis, destruction of parietal cells leads to pernicious anemia (vitamin B12 deficiency).

---

Diagnosis

Diagnosis of gastritis begins with a thorough clinical history, during which the physician evaluates:

• Current symptoms and their duration
• Dietary habits and food triggers
• Medication use (particularly NSAIDs, aspirin, corticosteroids)
• Alcohol and tobacco use
• Family history of gastric disease or cancer
• Presence of other autoimmune conditions

The modern diagnostic approach aims not only to confirm the presence of inflammation but, critically, to identify the underlying cause so that treatment can be precisely targeted.

Testing for Helicobacter Pylori

Identifying H. pylori infection is a priority in any patient with gastritis, as it represents the most common treatable cause. Current clinical guidelines favor non-invasive, high-accuracy tests:

• Urea Breath Test (UBT): Considered the “gold standard” among non-invasive tests, with sensitivity and specificity exceeding 95%. The patient ingests a small quantity of ¹³C-labeled urea; if H. pylori is present, its urease enzyme splits the urea, and labeled CO₂ is detected in exhaled breath samples collected 30 minutes later.

  • PPIs must be stopped at least 2 weeks, and antibiotics at least 4 weeks, before testing to avoid false-negative results

• Stool antigen test: A highly reliable fecal examination that detects active H. pylori antigens in stool samples, with accuracy exceeding 90%

• Serology (blood test for IgG antibodies): Less useful for initial diagnosis because antibodies may persist for months or years after successful eradication, making it impossible to distinguish between past and current active infection

Gastroscopy and Mucosal Assessment

Upper GI endoscopy (gastroscopy / EGDS) remains the definitive diagnostic examination. Using a flexible fiber-optic endoscope, the physician directly visualizes the gastric walls, identifying signs of:

• Mucosal redness and edema
• Erosions or ulcers
• Bleeding points
• Structural changes suggesting atrophy or metaplasia

Biopsy is an essential component of gastroscopy for gastritis evaluation. Small tissue samples are collected and submitted for:

• Rapid urease test (RUT): Quick bedside confirmation of H. pylori presence (result in 1 hour)
• Histological analysis: Microscopic examination to grade inflammation severity, identify atrophic changes, intestinal metaplasia, or dysplasia
• Confirmation or exclusion of atrophic gastritis with OLGA staging
• Exclusion of precancerous lesions or malignancy

According to the Sydney System, a minimum of 5 biopsies from standardized locations (antrum, angularis incisura, and body) is recommended to maximize diagnostic accuracy.

Supportive Tests and Monitoring

In specific clinical situations, the physician may request:

• Complete blood count (CBC): To detect anemia (low hemoglobin) resulting from chronic micro-bleeding
• Serum iron, ferritin, and transferrin saturation: To assess iron stores in suspected iron-deficiency anemia
• Vitamin B12 levels: In suspected autoimmune gastritis or when pernicious anemia is a concern
• Anti-parietal cell antibodies (APCA) and anti-intrinsic factor antibodies (AIFA): Serological markers for autoimmune gastritis
• Serum gastrin and pepsinogen I/II ratio: Non-invasive biomarkers useful for identifying advanced atrophic changes, particularly when endoscopy is being considered

---

Treatment and Therapy

The primary goals of gastritis treatment are:

1. Resolve the underlying inflammation
2. Relieve symptoms
3. Prevent complications (ulcers, bleeding, neoplasia)

Treatment is closely individualized based on the identified cause.

Eradication of Helicobacter Pylori

When H. pylori infection is confirmed, antibiotic therapy is essential and should be offered to all infected patients with gastritis. Due to rising global rates of antibiotic resistance (particularly to clarithromycin and metronidazole), current international guidelines increasingly recommend quadruple therapy as first-line treatment:

Bismuth Quadruple Therapy (BQT), lasting 10 to 14 days

Concomitant Quadruple Therapy (non-bismuth): 14 days

A PPI is combined with amoxicillin, clarithromycin, and metronidazole, all given at the same time.

Eradication must always be confirmed with a urea breath test or stool antigen test performed at least 4–6 weeks after completing therapy and at least 2 weeks after stopping PPIs. Failure to confirm eradication risks persistent infection and ongoing mucosal damage.

Successful H. pylori eradication leads to resolution of gastritis in most patients and significantly reduces the risk of peptic ulcer recurrence, gastric cancer, and MALT lymphoma.

Acid Management and Mucosal Protection

Reducing gastric acid exposure is essential to allow the mucosa to heal. Available options include:

• Proton Pump Inhibitors (PPIs): The most effective class of acid-suppressing drugs. Examples include omeprazole, lansoprazole, pantoprazole, and esomeprazole. They work by irreversibly blocking the H⁺/K⁺-ATPase enzyme (“proton pump”) in parietal cells, reducing acid production by up to 90%.

  • Long-term PPI use (beyond 8 weeks) carries potential risks including magnesium deficiency, vitamin B12 malabsorption, increased susceptibility to C. difficile infection, and rebound acid hypersecretion upon discontinuation. Use at the lowest effective dose for the shortest necessary duration.

• P-CABs (Potassium-Competitive Acid Blockers): A newer class (e.g., vonoprazan) offering faster onset and more consistent acid suppression than traditional PPIs, particularly useful in H. pylori eradication regimens in areas with high clarithromycin resistance.

• H₂ receptor antagonists: (for example, famotidine or ranitidine) are less potent than PPIs but remain useful for mild symptoms or as add-on therapy

• Mucosal protective agents / Cytoprotectants:

  • Sucralfate: Forms a protective mechanical barrier over ulcerated areas
  • Hyaluronic acid + chondroitin sulfate combinations: Provide a physical shield over the inflamed mucosa, offering symptom relief
  • Bismuth compounds: Coat and protect the mucosa while also having antibacterial activity against H. pylori

• Antacids and alginates: Over-the-counter options for managing occasional symptoms and associated reflux; provide rapid but short-lived symptom relief

Treatment of Specific Forms

Gastritis from NSAIDs

1. Discontinue the offending drug whenever medically feasible. This is the most important first step
2. If the NSAID cannot be stopped (e.g., in patients requiring long-term aspirin for cardiovascular protection), co-prescribe a PPI to be taken consistently throughout NSAID use
3. Consider switching to a selective COX-2 inhibitor, such as celecoxib, if anti-inflammatory therapy must continue. These medications have a significantly lower risk of GI mucosal damage
4. For pain management without anti-inflammatory need: Paracetamol (acetaminophen) is considerably safer for the gastric mucosa

Autoimmune Gastritis

There is currently no treatment capable of halting the autoimmune attack on parietal cells. Management focuses on:

• Vitamin B12 replacement: This is typically administered by intramuscular injection, with doses of 1000 µg per month or more frequently at first. Oral supplementation at high doses, such as 1000 to 2000 µg per day, may also be effective through passive absorption; however, it is generally considered less reliable
• Iron supplementation: Oral or intravenous, for concurrent iron-deficiency anemia
• Regular endoscopic surveillance: Given the elevated risk of gastric carcinoid tumors and adenocarcinoma in long-standing autoimmune gastritis
• Screening for associated autoimmune conditions: Particularly thyroid disease and type 1 diabetes

Lifestyle and Diet Modifications

Behavioral and dietary changes are a cornerstone of gastritis management and can dramatically reduce reliance on medication:

• Meal frequency and volume: Prefer 5 small meals daily over 2–3 large ones. Smaller meals reduce the peak acid secretory response and provide more consistent buffering of gastric acid throughout the day.

• Dietary choices: Avoid foods that excessively stimulate acid secretion or directly irritate the mucosa:

  • Fried and fatty foods
  • Excess caffeine (coffee, energy drinks, strong tea)
  • Chocolate and mint (which relax the lower esophageal sphincter)
  • Hot spices and chili
  • Highly acidic foods (tomato products, citrus)

• Smoking cessation: Smoking impairs mucosal blood flow, delays healing, reduces PPI efficacy, and is an independent risk factor for gastric cancer. Every effort to quit smoking directly benefits gastric health.

• Alcohol reduction or elimination: Alcohol directly damages the mucosal barrier and impairs healing.

• Stress management: Given the strong gut-brain axis connection, relaxation techniques (mindful breathing, progressive muscle relaxation, yoga), moderate physical exercise, and psychological support can reduce stress-related acid hypersecretion and improve symptom control.

---

Diet

Careful attention to diet is the first and most accessible step in managing gastritis effectively. If episodes of gastritis or heartburn are frequent, adopting smaller, more frequent meals can be particularly beneficial. This approach reduces the peak acid load on the stomach and provides more consistent neutralization throughout the day.

Foods to favor:

• Bland, low-acid foods: Rice, oatmeal, potatoes, bread, pasta (without heavy sauces)
• Lean proteins: Chicken, turkey, fish, eggs (boiled or baked)
• Non-acidic vegetables: Carrots, peas, green beans, broccoli (cooked)
• Low-fat dairy (in small amounts, if tolerated): Some patients find milk temporarily soothing, though it stimulates acid rebound in others
• Probiotic foods: Yogurt with live cultures may help restore gut microbiome balance, particularly after antibiotic therapy
• Ginger: Has documented anti-nausea and mild anti-inflammatory properties; ginger tea may provide gentle symptom relief

Foods and habits to avoid:

• Fried, fatty, and heavily processed foods
• Spicy foods and hot peppers
• Citrus fruits and juices
• Tomatoes and tomato-based products (sauces, ketchup)
• Coffee and caffeinated beverages (including decaf, which is still acidic)
• Carbonated drinks
• Alcohol (all forms)
• Chocolate and peppermint
• Eating very large meals or eating too quickly
• Lying down immediately after eating (wait at least 2–3 hours before reclining)

---

Prevention

While H. pylori infection is not always preventable, the following measures can significantly reduce the risk of developing gastritis or experiencing recurrences:

• Limit or eliminate alcohol: Alcohol directly irritates and erodes the gastric mucosa, promoting inflammation and bleeding. Moderation or complete abstinence is strongly recommended.

• Quit smoking: Tobacco smoke impairs the action of the protective mucous layer, increases gastric acidity, slows healing, and is a major independent risk factor for gastric cancer. If you have smoked for years, speak to your doctor about evidence-based cessation strategies.

• Choose safer pain relievers: When possible, avoid NSAIDs (aspirin, ibuprofen, naproxen). These drugs can cause or worsen gastric inflammation. Switch to paracetamol (acetaminophen) when simple pain relief, without an anti-inflammatory effect, is sufficient.

• Take NSAIDs correctly when necessary: Always take with food or milk, use the lowest effective dose for the shortest possible duration, and discuss co-prescribing a PPI with your physician if long-term use is unavoidable.

• Practice good hygiene: Thorough handwashing before meals and after using the bathroom reduces the risk of H. pylori transmission via the fecal-oral route.

• Follow your doctor’s recommendations: If you have a history of gastritis or peptic ulcer disease, your physician may recommend maintenance therapy with a low-dose antacid or antiulcer medication to prevent recurrence.

• Monitor and test for H. pylori: If you have a first-degree relative with gastric cancer or a history of peptic ulcer disease, ask your doctor about testing for H. If H. pylori test results are positive, eradication significantly reduces the long-term risk of gastric cancer.

---

Frequently Asked Questions

What Is Gastritis?

Gastritis is inflammation of the stomach lining (gastric mucosa). It can be acute (sudden onset, short duration) or chronic (gradual, persistent), erosive (with mucosal damage) or non-erosive, and can be caused by a variety of factors including bacterial infection, medications, alcohol, and autoimmune processes.

What Is Nervous Gastritis?

In strict medical terms, “nervous gastritis” refers to stress-induced gastritis. This condition is caused by extreme physiological stress, such as severe burns, major trauma, critical illness, or major surgery. This is a distinct, serious condition involving actual mucosal damage.

In everyday language, “nervous gastritis” often refers to functional dyspepsia. This condition involves uncomfortable digestive symptoms triggered by psychological stress, anxiety, or emotional distress. Importantly, it occurs without any measurable mucosal inflammation. For a detailed discussion of this topic, see our dedicated article on nervous gastritis and functional dyspepsia.

How Long Does Gastritis Last?

In most cases, gastritis has an excellent prognosis when treated appropriately. Duration depends strongly on the underlying cause:

• H. pylori-related gastritis: Typically resolves after successful antibiotic eradication therapy (2–4 weeks total treatment + confirmation)
• NSAID-induced gastritis: Often resolves within weeks of stopping the causative drug, with or without acid-suppressing medication
• Autoimmune gastritis: A chronic condition without a curative treatment. It is managed long-term through vitamin supplementation and surveillance
• Untreated chronic gastritis: Can persist for years or even decades, with risk of progressive complications

How Is Gastritis Treated?

Effective gastritis treatment combines several elements:

1. Identify and eliminate the cause: Stop NSAIDs, reduce alcohol, eradicate H. pylori
2. Lifestyle modifications: Dietary adjustments, smoking cessation, stress management
3. Antibiotic therapy: For confirmed H. pylori infection (quadruple therapy, 10–14 days)
4. Acid-suppressing medications: PPIs or H2 blockers, as prescribed by the physician
5. Mucosal protective agents: Sucralfate, bismuth compounds, cytoprotectant formulations when indicated
6. Vitamin supplementation: B12 and/or iron replacement in cases of nutritional deficiency

Can Gastritis Cause Cancer?

Chronic gastritis, particularly when associated with H. pylori infection, remains a significant health concern. This condition involves long-term inflammation of the stomach lining, often leading to discomfort and potential complications. Early diagnosis and treatment are crucial to prevent further damage and improve patient outcomes. pylori infection, advanced atrophy, or intestinal metaplasia all carry an elevated risk of gastric cancer over time. However, the absolute risk remains low in most patients, and H. pylori eradication has been shown to significantly reduce this risk. Patients with advanced atrophic gastritis (OLGA stages III–IV) should undergo regular endoscopic surveillance every 2–3 years as recommended by current European guidelines.

---

Sources and Bibliography

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Gastritis and Gastropathy. https://www.niddk.nih.gov/health-information/digestive-diseases/gastritis-gastropathy
• Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-1762. https://doi.org/10.1136/gutjnl-2022-327745
• Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631-636. https://doi.org/10.1136/gut.2006.106666
• Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613-624. https://doi.org/10.1016/S0140-6736(16)32404-7
• Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II). Endoscopy. 2019;51(4):365-388. https://doi.org/10.1055/a-0859-1883
• Lenti MV, Corazza GR, Di Sabatino A. Autoimmune Gastritis. New England Journal of Medicine. 2023;388(23):2147-2157. https://doi.org/10.1056/NEJMra2203353
• Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori Eradication Therapy to Prevent Gastric Cancer: Systematic Review and Meta-analysis. Gut. 2020;69(12):2113-2121. https://doi.org/10.1136/gutjnl-2020-320839
• American College of Gastroenterology (ACG). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology. 2017;112(2):212-239. https://doi.org/10.1038/ajg.2016.563
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353-1367. https://doi.org/10.1136/gutjnl-2015-309252
• Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology. 1999;117(1):17-25.